PlainRecalls
FDA Drug Moderate Class II Ongoing

Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54

Reported: January 3, 2024 Initiated: December 11, 2023 #D-0205-2024

Product Description

Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54

Reason for Recall

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Details

Units Affected
161,664 bottles
Distribution
CA and AR
Location
Earth City, MO

Frequently Asked Questions

What product was recalled?
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54. Recalled by Legacy Pharmaceutical Packaging LLC. Units affected: 161,664 bottles.
Why was this product recalled?
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 3, 2024. Severity: Moderate. Recall number: D-0205-2024.